McCormick & Company, Incorporated Non-VTG CS MKC

McCormick & Company, Inc se dedica a la fabricación, comercialización y distribución de especias, mezclas de condimentos, condimentos y otros productos sabrosos para la industria alimentaria, minoristas de alimentos, fabricantes de alimentos y negocios de servicios de alimentos. La empresa también colabora con varias compañías que participan en la fabricación y venta de productos sabrosos. La empresa opera en dos segmentos comerciales: Consumidor y Soluciones de Sabor. Las instalaciones de ventas, distribución y producción de la empresa se encuentran en América del Norte, Europa y China. También cuenta con instalaciones adicionales en Australia, India, América Central, Tailandia y Sudáfrica.

Con 22 acciones de MKC (USD 1.000,12) habrías recibido USD 31,68 en dividendos en los últimos 12 meses.

MKC hizo una división de acciones (split) de 2:1 el 1 de diciembre de 2020: cada acción se convirtió en 2. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• The Motley Fool 4 oct

  2 High-Yield Stocks to Buy in October Without Any Hesitation

  The author recommends two high-yield dividend stocks for October: Medtronic (MDT), which has completed a business overhaul and is approaching Dividend King status with a 3.3% yield, and McCormick (MKC), a consumer staples company with 39 years of dividend increases and a 4.2% yield that is acquiring Unilever's food business to roughly double its sales.

  

• The Motley Fool 2 oct

  Cooper Companies Director Kurzius Buys $549,300 in Shares. Is the Eye Care Stock About to Rally?

  Lawrence Erik Kurzius, a Director at Cooper Companies, purchased 10,000 shares worth $549,300 at $54.93 per share on September 16, 2026, increasing his total holdings to 31,099 shares. The insider buy signals confidence in the company's recovery prospects following a 16% stock decline over the past year. The article notes that insider purchases typically predict higher share prices within 30 days and suggest management believes in the company's long-term growth, particularly after deciding to retain its surgical unit rather than divest it.

  

• Zacks Investment Research 1 oct

  MKC Q3 Earnings Beat Estimates on Margin Gains and Mexico Growth

  McCormick & Company delivered solid Q3 fiscal 2026 results with net sales rising 17.4% to $2,024.8 million, driven by the McCormick de Mexico acquisition and 1.9% organic growth. Adjusted earnings of 86 cents per share beat consensus estimates, while adjusted gross margin expanded 180 basis points to 39.3%. The company reaffirmed its fiscal 2026 outlook but expects higher commodity and freight costs in Q4, with a packaging constraint potentially reducing full-year organic growth by 30 basis points.

  

• Zacks Investment Research 1 oct

  McCormick (MKC) Surpasses Q3 Earnings and Revenue Estimates

  McCormick reported Q3 earnings of $0.86 per share, beating consensus estimates of $0.75, with revenues of $2.02 billion exceeding expectations. However, the stock carries a Zacks Rank #4 (Sell) rating due to unfavorable estimate revisions and has underperformed the market by 31.9% year-to-date. Mondelez is expected to report Q3 earnings of $0.71 per share with revenues of $9.97 billion.

  

• Zacks Investment Research 29 sept

  McCormick Readies for Q3 Earnings: What to Expect From MKC Stock?

  McCormick & Company is expected to report Q3 2026 revenues rising 14.7% to ~$2 billion, but earnings may fall 11.8% to 75 cents per share. Growth drivers include the Flavor Solutions segment, pricing actions, and CCI productivity savings, while headwinds include consumer price sensitivity, competitive pressures, and inflationary expenses. The company carries a Zacks Rank #4 (Sell) with a negative Earnings ESP of -1.97%, suggesting limited likelihood of an earnings beat.